Home › Funds › CAPSTONE INVESTMENT ADVISORS, LLC › GH

CAPSTONE INVESTMENT ADVISORS, LLC position in GH

GUARDANT HEALTH INC · Health Care

CAPSTONE INVESTMENT ADVISORS, LLC reported holding 13,500,000 shares of GH (GUARDANT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$39.6M, representing 0.39% of its reported portfolio and ranking #37 among its reported holdings. CAPSTONE INVESTMENT ADVISORS, LLC has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.50M sh
Reported value held$39.60M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How CAPSTONE INVESTMENT ADVISORS, LLC's GH position evolved

CAPSTONE INVESTMENT ADVISORS, LLC first disclosed a stake in GH in Q3 2023 at 31,200,000 shares (US$21.6M). The position peaked in Q3 2026 at 13,500,000 shares, worth US$39.6M. Across 13 filings, CAPSTONE INVESTMENT ADVISORS, LLC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 13,500,000 shares valued at US$39.6M — an increase of 13,498,309 shares quarter over quarter.. Notable position changes include a 254151% increase in Q1 2024 (shares rose 40% over the following quarter), a 390476% increase in Q1 2026 (shares rose 62% over the following quarter), a 798244% increase in Q3 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 31.20M $21.61M New
Q4 2023 12.47K $337.26K Reduce
Q1 2024 31.70M $21.70M Add
Q2 2024 25.70M $19.94M Reduce
Q3 2024 20.70M $16.67M Reduce
Q4 2024 14.70M $12.38M Reduce
Q1 2025 7.20M $6.40M Reduce
Q2 2025 15.14K $787.99K Reduce
Q3 2025 37.80K $2.36M Add
Q4 2025 2.24K $228.69K Reduce
Q1 2026 8.74M $9.03M Add
Q2 2026 1.69K $253.70K Reduce
Q3 2026 13.50M $39.60M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GH and 13F data

GH (GUARDANT HEALTH INC) is a Health Care company. 60 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$500.4M), FEDERATED HERMES, INC. (US$445.6M), EVENTIDE ASSET MANAGEMENT, LLC (US$331.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GH

All GH fund holders →

FAQ

How long has CAPSTONE INVESTMENT ADVISORS, LLC held GH?

CAPSTONE INVESTMENT ADVISORS, LLC has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAPSTONE INVESTMENT ADVISORS, LLC's current position in GH?

As of Q3 2026, CAPSTONE INVESTMENT ADVISORS, LLC holds 13.50M shares of GH (GUARDANT HEALTH INC), valued at $39.60M, representing 0.39% of its reported portfolio and ranking #37.

Has CAPSTONE INVESTMENT ADVISORS, LLC been buying or selling GH?

In the latest 13F filing (Q3 2026), CAPSTONE INVESTMENT ADVISORS, LLC increased its position in GH. The position peaked in Q3 2026 at 13.50M shares.

Which other funds hold GH?

Other major institutional holders of GH include Deep Track Capital, LP, FEDERATED HERMES, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.